HR3239-119

Introduced

To improve commercialization activities in the SBIR and STTR programs, and for other purposes.

119th Congress Introduced May 7, 2025

Summary

What This Bill Does

The bill creates phase flexibility authority for SBIR/STTR programs expanded to all federal agencies with spending caps, requires mandate for each federal SBIR/STTR agency to designate a Technology Commercialization Official with reporting duties, and creates expanded technical and business assistance for SBIR/STTR awardees with higher funding caps and more vendor flexibility. It relies on grants, compliance mandates, reporting requirements, and exemptions. The main policy areas are Finance, Defense, Healthcare, and Technology.

Who Benefits and How

Small businesses receiving SBIR/STTR awards could gain revenue opportunities, Small businesses seeking commercialization guidance could gain revenue opportunities, and Technical assistance vendors could gain revenue opportunities.

Who Bears the Burden and How

Federal agencies with SBIR/STTR programs would take on compliance duties, SBA and federal agencies would take on compliance duties, and Federal agencies with I-Corps programs would take on compliance duties.

Key Provisions

  • Creates phase flexibility authority for SBIR/STTR programs expanded to all federal agencies with spending caps.
  • Requires mandate for each federal SBIR/STTR agency to designate a Technology Commercialization Official with reporting duties.
  • Creates expanded technical and business assistance for SBIR/STTR awardees with higher funding caps and more vendor flexibility.
  • Requires mandatory I-Corps participation option for SBIR/STTR awardees at agencies with I-Corps programs.
  • Requires annual commercialization impact assessment report for frequent SBIR/STTR Phase II awardees measuring revenue, patents, jobs, and investment.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

The bill creates phase flexibility authority for SBIR/STTR programs expanded to all federal agencies with spending caps, requires mandate for each federal SBIR/STTR agency to designate a Technology Commercialization Official with reporting duties, and creates expanded technical and business assistance for SBIR/STTR awardees with higher funding caps and more vendor flexibility.

Key Policy Areas

Finance, Defense, Healthcare, Technology

Primary Purpose

The bill creates phase flexibility authority for SBIR/STTR programs expanded to all federal agencies with spending caps, requires mandate for each federal SBIR/STTR agency to designate a Technology Commercialization Official with reporting duties, and creates expanded technical and business assistance for SBIR/STTR awardees with higher funding caps and more vendor flexibility.

Policy Domains

Finance Defense Healthcare Technology

Section 2 - Peer Review Commercialization Criteria

Identified Gains
  • Small businesses receiving SBIR/STTR awards
  • Small businesses seeking commercialization guidance
  • Technical assistance vendors
  • Department of Defense
  • National Institutes of Health
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Department of Defense:
Technical assistance vendors:
National Institutes of Health:
Small businesses receiving SBIR/STTR awards:
Small businesses seeking commercialization guidance:
Identified Costs
  • Federal agencies with SBIR/STTR programs
  • SBA and federal agencies
  • Federal agencies with I-Corps programs
  • USPTO
  • Small businesses with 50+ Phase II awards
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
USPTO:
SBA and federal agencies:
Federal agencies with I-Corps programs:
Federal agencies with SBIR/STTR programs:
Small businesses with 50+ Phase II awards:

Legislative Progress

Introduced
Introduced Committee Passed
May 7, 2025

Ms. Houlahan (for herself and Mr. Balderson) introduced the following …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
6 mentions across 5 clauses
+2 positive -4 negative

Department of Defense, Federal agencies with I-Corps programs, Federal agencies with SBIR/STTR programs

Positive-direction: Department of Defense, National Institutes of Health

Negative-direction: Federal agencies with I-Corps programs, Federal agencies with SBIR/STTR programs, SBA and federal agencies, USPTO

Small Business
3 mentions across 3 clauses
+2 positive -1 negative

Small businesses receiving SBIR/STTR awards, Small businesses seeking commercialization guidance, Small businesses with 50+ Phase II awards

Positive-direction: Small businesses receiving SBIR/STTR awards, Small businesses seeking commercialization guidance

Negative-direction: Small businesses with 50+ Phase II awards

Professional Services
1 mention across 1 clause
+1 positive

Technical assistance vendors

Technology
1 mention across 1 clause
+1 positive

Cybersecurity service providers

6/8
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Finance Defense Healthcare Technology
Domains
Small Business
Actor Mappings
"the_administrator"
→ Administrator of the Small Business Administration
Domains
Small Business Science & Technology
Domains
Small Business
Domains
Small Business Science & Technology
Domains
Small Business
Actor Mappings
"the_administrator"
→ Administrator of the SBA
Domains
Intellectual Property Small Business
Actor Mappings
"the_director"
→ Under Secretary of Commerce for IP / Director of USPTO
"the_administrator"
→ Administrator of the SBA

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology